The latest edition of Vital Signs presents research advances in understanding the mechanisms and origins of cancer, developments on treatments, preventions, and cures. The lead article, "Taking a Jab at Cancer", describes how cancer vaccine developers are overcoming scientific challenges and investor resistance.
The 61st ASMS Conference on Mass Spectrometry and Allied Topics begins on Sunday, June 9 with tutorial lectures at 5:00 pm and the opening session and plenary lecture at 6:45 pm. A welcome reception in the poster/exhibit hall will follow.
Determining the safety and toxicity of a drug is an extremely important and complicated task. While in the early discovery phases for a new drug, testing the drug’s toxicology has become an integral part of early research.
IBC Life Sciences: TIDES: Oligonucleotide and Peptide Therapeutics from Research through CommercializationMarch 28, 2013 4:01 pm Events
The TIDES Summit features five tracks that cover the full spectrum of advances in oligonucleotide and eptide discovery, development and manufacturing.
Now in its 24th year, Antibody Engineering & Therapeutics has earned its reputation by consistently offering the most current academic research findings and most recent industry updates.
IBC has taken the lead to bring all the industry experts together to give you the answers you need to move ahead your discovery, design or development program.
IBC's Next Generation Protein Therapeutics Summit is the only conference on the market which consistently brings together every leading company and academic scientist working in alternative scaffold and next-generation protein therapeutic development.
The 9th annual World Stem Cell Summit is the best way to learn about the latest research and challenges in translational medicine, as well as areas of promise. Take a break from 65 hours of speaker presentations and ongoing exhibitions to network with people from over 40 countries during a variety of small group events and social gatherings.
Capsugel’s Vcaps Plus capsules are produced without a gelling agent that can delay dissolution and lead to unwanted issues during product development.
The United States Pharmacopeial Convention (USP) will host the Fifth Bioassay Workshop at its headquarters in Rockville, Md. Manufacturers, regulators and other stakeholders in the biopharmaceutical arena will present on key bioassay-related topics.
SfN's annual meeting provides the world's largest forum for neuroscientists to debut research and network with colleagues from around the world.
American Association of Pharmaceutical Scientists annual meeting
In the June issue of Drug Discovery & Development, we detail how guidance from the FDA may finally allow omics-based diagnostics to flourish. Also discussed are advances in multiplex assays, using structure-based drug design to visualize molecules, new ways to predict pathway effects, and a better technique to image the heart in vivo.
In the May issue of Drug Discovery & Development, Big Pharma talks about the effects of revenue losses on research paradigms. Also discussed are the ways in which immunoassays can improve the study of EGFR signaling, mass spectrometry's impact on drug testing, and ways to help build an effective clinical trial supply chain.
SLAS 2013 will feature 4,500 of the best global laboratory science and technology minds coming together to learn, explore, and gain repeatable inspiration from leaders in the field.
Natural Product Purification of Lycopene and β‐Carotene Using Flash Column Sample Clean‐up Prior to High Pressure Normal Phase Chromatography on the Gilson PLC 2020May 16, 2012 3:25 pm White Papers Comments
Purifying low level compounds, such as those typically isolated from natural products, is an area of growing interest for the purpose of discovering new chemical entities.